Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-06-14Clinical Trial Update: A Pilot Randomized Trial of a Comprehensive Transitional Care Program for Colorectal Cancer Patients [NA]
ClinicalTrials.gov reports withdrawal of a pilot randomized trial evaluating a comprehensive transitional care program for colorectal cancer…
-
CLINICAL_TRIALS trial_result · 2016-06-10Clinical Trial Update: Colorectal Cancer (CRC) Cetuximab Elderly Frail [Phase 2]
Phase 2 trial evaluating cetuximab in elderly frail patients with metastatic colorectal cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy [Phase 2]
A Phase 2 trial evaluating intra-arterial hepatic bevacizumab in combination with systemic chemotherapy for colorectal cancer has completed.
-
CLINICAL_TRIALS research · 2016-06-08Clinical Trial Update: Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer [Phase 3]
Phase 3 clinical trial evaluating adjuvant chemotherapy plus Huaier Granule for high-risk stage II/III colorectal cancer. The current status…
-
FDA approval · 2016-06-07FDA Approved: STIVARGA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Stivarga (regorafenib) submitted by Bayer HealthCare Pharmaceuticals Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-06-07Clinical Trial Update: Prospective Trial to Compare ADR of G-EYE™ Colonoscopy With Standard Colonoscopy [NA]
An ongoing prospective trial aims to compare the adenoma detection rate of G-EYE colonoscopy with standard colonoscopy. The document lists a…
-
FDA approval · 2016-06-07FDA Approved: OXALIPLATIN — Original Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved the original application for Oxaliplatin from Qilu Pharmaceutical Co., Ltd., a generic injectable anticancer drug.
-
CLINICAL_TRIALS research · 2016-06-03Clinical Trial Update: Metabolomic Phenotyping After Surgery for Colon Cancer: Study of Novel Predictive Biomarkers
A clinical trial update describing a study of metabolomic phenotyping after surgery in colorectal cancer to identify novel predictive biomar…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Comparison of Triphasic CT, PET and MR Tumour With Pathological Findings in Colorectal Cancer Liver Metastases [NA]
Completed clinical trial comparing triphasic CT, PET, and MR imaging against pathological findings in colorectal cancer liver metastases. Th…
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery [Phase 3]
Phase 3 trial evaluating a first-line combination chemotherapy regimen in older patients with unresectable metastatic colorectal cancer. The…
-
CLINICAL_TRIALS research · 2016-05-24Clinical Trial Update: Limiting Chemotherapy Side Effects by Using Moxa [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating whether moxa (moxibustion) can limit chemotherapy-related side effects in patients with breast o…
-
CLINICAL_TRIALS withdrawal · 2016-05-20Clinical Trial Update: Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer [NA]
A clinical trial evaluating ferumoxytol-enhanced MRI for detecting lymph node metastases in colorectal cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Quality of Life of Patients With Colorectal Neoplasm and Cost-Effectiveness Analysis of Colorectal Cancer Screening
A completed clinical trial update examining quality of life in patients with colorectal neoplasms and evaluating the cost-effectiveness of c…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Colorectal Cancer Screening Intervention in UWPN Clinics [NA]
This clinical trial update reports the completion of a colorectal cancer screening intervention study conducted in UWPN clinics.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Axitinib as Maintenance Treatment in Patients With Metastatic CRC [Phase 2]
A Phase 2 trial evaluating axitinib as maintenance therapy for metastatic colorectal cancer has been terminated.
-
CLINICAL_TRIALS research · 2016-05-12Clinical Trial Update: Diet and Physical Activity Intervention in CRC Survivors [Phase 2]
This entry reports a Phase 2 clinical trial evaluating a diet and physical activity intervention for colorectal cancer survivors, with the s…
-
FDA approval · 2016-05-11FDA Approved: OXALIPLATIN — Original Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved Qilu Pharmaceutical Co., Ltd.'s generic oxaliplatin under Original Application (ANDA204616), providing a generic option for col…
-
CLINICAL_TRIALS guidance · 2016-05-06Clinical Trial Update: PERCIST Criteria for Response Evaluation With Solid Tumors
This document provides an update on PERCIST criteria for PET-based response evaluation in solid tumors, outlining how response endpoints may…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens [Phase 3]
Phase 3 trial evaluating Xaliproden for recovery from severe neuropathy after oxaliplatin-based adjuvant chemotherapy in colorectal cancer p…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy. [Phase 3]
Phase 3 trial evaluating whether Xaliproden (SR57746A) can prevent oxaliplatin/5-FU/LV–induced neurotoxicity in metastatic colorectal cancer…
-
FDA approval · 2016-05-03FDA Approved: IRINOTECAN HYDROCHLORIDE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s Original Application for irinotecan hydrochloride, establishing a generic version of irinotecan for cancer treat…
-
CLINICAL_TRIALS withdrawal · 2016-05-03Clinical Trial Update: Chemotherapy-Induced Peripheral Neuropathy Survey
A clinical trial evaluating chemotherapy-induced peripheral neuropathy has been withdrawn. The study involved patients with breast cancer, c…
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer
An observational study of capecitabine (Xeloda) across metastatic colorectal cancer, adjuvant colon cancer, advanced gastric cancer, and bre…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: The Feasibility of an Active Lifestyle Programme in Patients Recovering From Colorectal Cancer [NA]
A completed clinical trial evaluating the feasibility of an active lifestyle program for patients recovering from colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Impact of Early and Active Nutritional and Dietary Management grade3 or More Toxicities Induced by Chemotherapy and Targeted Therapies Administered to Patients as First Intention for Non Surgical Metastatic Colorectal Cancer [NA]
A completed clinical trial evaluating early nutritional and dietary management to reduce grade 3 or higher toxicities from chemotherapy and …